Diphenhydramine Hydrochloride Tablet, Coated
FDA Label NDC 49483-329

13 label sections · Submitted to the FDA by Time-cap Labs, Inc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Time-cap Labs, Inc for the product Diphenhydramine Hydrochloride (NDC 49483-329). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - ask doctor, otc - ask doctor/pharmacist, otc - do not use, otc - keep out of reach of children, warnings, otc - pregnancy or breast feeding, otc - purpose, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Enter section text here

* Please review the disclaimer below.